Company profile | PROGEN helps scientists worldwide drive biopharmaceutical progress to provide reliable treatments for patients. Our mission is to provide high-quality products that help improve existing research processes and make new therapies safe and affordable. The PROGEN team team consists of life science and AAV experts and is partnered with specialists within the field of gene therapy. We strive to understand what scientists need, so we can create solutions which solve the challenges within biotech and pharma.
|
Products & Services | AAV Titration ELISAs for different serotypes, AAV Antibodies (Capsid Protein, Particle, Human Chimeric, Replicase), AAV Standards (Full & Empty Capsids, ELISA Controls, AAV Dip`n`Check, Density Gradient Media, Research Antibodies
|
References and export activities | PROGEN is serving customers worldwide – direct and via distributors. We have a strong network of partners in both academia and industry and collaborate with different partners. Our mother company is r-biopharm AG in Darmstadt, Germany.
|
Target group | Biopharma working in the Gene Therapy Field, CDMOs, CROs, Biotech, Academic/Public Institutes
|
Competitive advantages | DIN EN ISO 13485 certified manufacturing site in Germany; exclusive rights of AAV ELISA technology and AAV antibodies granted by the German Cancer Research Centre; high and reliable quality.
|
Ideal Business Partners | Biopharma, CDMOs, CROs, Research
|